Status:
COMPLETED
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium
Lead Sponsor:
University of Colorado, Denver
Conditions:
Colistin
Eligibility:
All Genders
18-89 years
Brief Summary
Colistin is a polymixin antibiotic used in the treatment of multidrug-resistant gram-negative infections. Given the limited use of colistin and previous challenges with laboratory assays to determine ...
Detailed Description
Colistin, also known as polymixin E, is a peptide antibiotic that demonstrates concentration-dependent bactericidal killing against gram-negative pathogens including Pseudomonas and Acinetobacter. Ori...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years old receiving intravenous colistimethate sodium for the treatment of infection
- Have cystic fibrosis and/or are critically ill (admitted to a critical care unit)
Exclusion
- Pregnancy
- Breastfeeding
- Prisoners
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02288429
Start Date
September 1 2013
End Date
June 1 2019
Last Update
June 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Hospital
Aurora, California, United States, 80045